S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 31.15 CNY -0.1%
Market Cap: 34.7B CNY
Have any thoughts about
Shenzhen Salubris Pharmaceuticals Co Ltd?
Write Note

Shenzhen Salubris Pharmaceuticals Co Ltd
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shenzhen Salubris Pharmaceuticals Co Ltd
Cash Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Cash Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
S
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Cash
ÂĄ914m
CAGR 3-Years
3 570%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash
ÂĄ22.4B
CAGR 3-Years
74%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash
ÂĄ8.8B
CAGR 3-Years
59%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash
ÂĄ22.3B
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash
ÂĄ14.1B
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
160%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash
ÂĄ391.7m
CAGR 3-Years
1 693%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shenzhen Salubris Pharmaceuticals Co Ltd's Cash?
Cash
914m CNY

Based on the financial report for Jun 30, 2024, Shenzhen Salubris Pharmaceuticals Co Ltd's Cash amounts to 914m CNY.

What is Shenzhen Salubris Pharmaceuticals Co Ltd's Cash growth rate?
Cash CAGR 3Y
3 570%

Over the last year, the Cash growth was 235 722%. The average annual Cash growth rates for Shenzhen Salubris Pharmaceuticals Co Ltd have been 3 570% over the past three years .

Back to Top